In combination with IDO-1, which can promote NSCLC lymph node metastasis and invasion, p53 suppresses the pathway of IDO-1, thereby indicating that the increased expression of p53 can inhibit NSCLC metastasis. The gene discussed is IDO1; the disease is non-small cell lung carcinoma.